Cancer has always been a significant challenge to the medical community due to its widespread and frequently unexpected character. White blood cell malignancies come in a variety of types, but leukaemia in particular has special complications that need creative treatment strategies. Antitumor medications have emerged as potent instruments in the revolution of white blood cell cancer treatment, marking a hopeful paradigm change in oncology in recent years.